Office for Life Sciences
The Office for Life Sciences (OLS), led by Lord Drayson, minister for science and innovation and founder of a biotech company, was set up in 2009 to develop measures to "improve the operating environment for UK life science companies".[1]
The OLS, in collaboration with representatives of the life sciences industry, academia, the NHS, and several government departments over a six month period, set up an initiative called The Life Sciences Blueprint, which, according to an article in the BMJ, has been described by representatives of different life science industries as a "major milestone."[2]
The BMJ article states that the Life Sciences Blueprint has come up with the idea of fast-tracking new drugs so that they do not have to go through the usual approvals process of the National Institute for Health and Clinical Excellence (NICE):
- Innovative drugs will be approved for NHS use without having first gone through the appraisal process of the National Institute for Health and Clinical Excellence (NICE), as part of a drive to stimulate the United Kingdom’s life sciences industry.[3]
Contents
Affiliations
Funding
Contact
- Address:
- ...
- ...
- ...
- ...
- Phone:
- ...
- Email:
- ...
- Website:
- ...
Resources
Notes
- ↑ Deborah Cohen, Innovative drugs will bypass NICE approval process to build cost effective data, BMJ 2009;339:b2887, 15 July 2009 (subscription req'd to view full article)
- ↑ Deborah Cohen, Innovative drugs will bypass NICE approval process to build cost effective data, BMJ 2009;339:b2887, 15 July 2009 (subscription req'd to view full article)
- ↑ Deborah Cohen, Innovative drugs will bypass NICE approval process to build cost effective data, BMJ 2009;339:b2887, 15 July 2009 (subscription req'd to view full article)
